Thereby, it is possible that inhibition of microglial NF-κB pathway is beneficial in SCA1, but that due to the low efficiency of Cre recombination in LysM Cre line, we did not reach the threshold of NF-κB inhibition necessary for the significant alteration of disease phenotype. Here, NFKB1 is linked to spinocerebellar ataxia type 1.